Here are relevant reports on : protein-therapeutics-market
-
Wheat Protein Market by Product (Gluten, Protein Isolate, Textured Protein, Hydrolyzed Protein), Form, Concentration, Application (Bakery & Snacks, Pet Food, Nutritional Bars & Drinks, Processed Meat, Meat Analogs) & Region - Global Forecast to 2028
According to MarketsandMarkets, the wheat protein market is projected to reach USD 3.2 billion by 2028, at a CAGR of 4.9% during the forecast period in terms of value. The key players in this market include ADM (US), Cargill, Incorporated (US), Tereos (France), Südzucker AG (US), MGP Ingredients (US), Roquette Frères (France), Glico Nutrition Foods Co., Ltd. (Japan), Kerry Group PLC (Ireland), Manildra Group (Australia), Kröner-Stärke (Germany), among others. The study includes an in-depth competitive analysis of these key players in the wheat protein market with their company profiles, recent developments, and key market strategies.
- Published: March 2023
- Price: $ 4950
- TOC Available:
-
Whey Protein Market, by Type (Whey Protein Concentrate (WPC), Whey Protein Isolate, Whey Protein Hydrolysate), by Application (Dairy, Confectionery, Bakery, Dietary Supplements, Instant Formula, Pharmaceuticals, Others), Region-Global Trends & Forecast - 2019
This report on the global whey protein market is focused on the whey protein available in the market and the expected future developments. The market segmentation is based on type, application, and regions. On the basis of type, whey protein market is segmented into whey protein concentrates, whey protein isolate, and whey protein hydrolysate. On the basis of applications, whey protein market is segmented into dairy, confectionery, bakery, and instant formula. Information contained in the report includes market sizes, forecast, trends, regulations and future developments in the changing global markets. Competitive information includes market shares of leading players, key developments and strategies deployed to win, along with the profiles of key market players.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Protein Alternatives Market by Source (Plant Protein, Microbial Protein, Insect Protein), Application (Food & Beverages, Animal Feed, Pet Food), Form, Nature, Production Process (Qualitative), & Region - Global Forecast to 2029
The protein alternatives market is projected to reach USD 25.2 billion by 2029, at a CAGR of 9.9% during the forecast period. Key market players in this include Tate & Lyle PLC (London), Kerry Group PLC (Ireland), DSM Firmenich (Switzerland), ADM (US), Cargill Incorporated (US), International Flavors & Fragrances Inc. (US), Ingredion (US), Roquette Frères (France), Wilmar International Ltd. (Singapore), Glanbia plc (Ireland), AGT Food and Ingredients (Canada), Tate & Lyle (UK), PURIS (US), Ynsect (France), Global bugs (Thailand), and Innovafeed (France).
- Published: June 2024
- Price: $ 4950
- TOC Available:
-
RNA Therapeutics Market by Product (Vaccines, Drugs), Type (mRNA Therapeutics, RNA Interference, Antisense Oligonucleotides), Indication (Infectious Diseases, Rare Genetic Diseases), End User (Hospitals & Clinics) & Region - Global Forecast to 2028
The global RNA therapeutics market, valued at US$32.2 billion in 2022, stood at US$13.7 billion in 2023 and is projected to advance at a resilient CAGR of 5.6% from 2023 to 2028, culminating in a forecasted valuation of US$18.0 billion by the end of the period. Growth in this market is largely driven by factors such as the increasing number of partnerships and collaborations among market players and RNA technology manufacturers, expanding modalities for RNA therapeutics, and the rising number of emergency use authorizations and approvals for COVID-19 booster vaccines.
- Published: September 2023
- Price: $ 4950
- TOC Available:
-
Monoclonal Antibody Therapeutics Market / mABs Therapeutics Market Size by Production Method (In-Vitro, In-Vivo), Sources (Human, Chimeric), Route of Administration (Intravenous, Subcutaneous), Therapy (Inflammatory & Autoimmune, Oncology, Hematology) - Global Forecast to 2029
The global monoclonal antibody therapeutics market, valued at US$222.6 billion in 2023, stood at US$252.6 billion in 2024 and is projected to advance at a resilient CAGR of 14.5% from 2024 to 2029, culminating in a forecasted valuation of US$497.5 billion by the end of the period. Driving factors of the market, including clinical trials, encompass increasing prevalence of complex diseases, advancements in biotechnology facilitating targeted treatments, regulatory support expediting approval processes, and robust investments in research and development.
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
Exosome Diagnostics and Therapeutics Market by Type (Diagnostics, Therapeutics), Product & Service (Instruments, Kits, Reagents), Source (Stem Cells, Blood, Blood Plasma, Urine), Application (Cancer, Musculoskeletal, CVD) - Global Forecast to 2032
The global exosome diagnostics and therapeutics market, valued at US$33 million in 2023, stood at US$59 million in 2024 and is projected to advance at a resilient CAGR of 81.2% from 2024 to 2032, culminating in a forecasted valuation of US$6,848 million by the end of the period. The growth of this market is driven by factors such as the increasing collaborations & commercialization initiatives, emerging potential of exosome-based liquid biopsy, and growing outsourcing of exosome manufacturing activities.
- Published: June 2024
- Price: $ 4950
- TOC Available:
-
Precision Fermentation Ingredients Market by Ingredient (Whey & Casein Protein, Egg White, Collagen Protein, Heme Protein), Microbe (Yeast, Algae, Fungi, Bacteria), End User, Food & Beverage Application, and Region - Global Forecast to 2030
The precision fermentation ingredients market is projected to expand from USD 5.02 billion in 2025 to USD 36.31 billion by 2030, at a CAGR of 48.6% during the forecast period. The report profiles key players such as Perfect Day, Inc. (US), Geltor (US), The EVERY Company (US), Impossible Foods Inc. (US), ImaginDairy Ltd. (Israel), Shiru, Inc. (US), FORMO FOODS GMBH (Germany), EDEN BREW (Australia), Change Foods (US), New Culture (US), Helaina Inc. (US), Naplasol (Belgium), Myco Technology, Inc. (US), Remilk Ltd. (Israel), and Triton Algae Innovations (US).
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
RNAI Technology Market- by Application (Research, Therapeutics) - Global Forecasts to 2019
The report presents the latest advances in RNAi technologies and their clinical implication as a therapeutic platform. It charts the current trends in RNAi therapeutics, and analyzes the opportunities and challenges faced by the RNAi companies. The focus will be on the clinical needs, patented technologies and the competitive landscape across geographies.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Global Nanomedical Devices and Therapeutics Market (2011-2016)
Nanomedicine, an application of nanotechnology in medical science, is an evolving market. It represents an important segment of nanotechnology which will significantly change the course of treating life threatening diseases. This, unlike other treatment options, is significantly expected to enhance efficacy and minimize overall adversities. Toxicity and environmental impact of nanoscale materials are the major problems nanomedicine. Research and development in nanomedicine is expected to offer a pool of novel products which will improve the health of patients. The robust product pipeline for nanobiomaterials poses a health picture of the market creates significant growth opportunities. However these will have to go through stringent testing protocols before commercialization.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Prostate Cancer Therapeutics Market (2010-2020) (Opportunity Analysis, Pipeline Assessment and Global Market Forecast)
Prostate cancer is the most frequently diagnosed cancer in men. In terms of loss of life from any disease, prostate cancer ranks eleventh; and it ranks sixth in terms of cancer-related mortality in men. The prostate cancer market has a huge demand for new and novel drugs that address unmet needs such as improved survival time, less toxicity, increased progression free survival, increased effectiveness, and lower cost.
- Published: November 2011
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
